Ftse Mib
33.739,90
-0,08%
DAX
19.848,77
-0,34%
S&P 500
6.040,04
1,10%
NASDAQ
20.031,13
1,35%
Bitcoin
98.104,76
-0,58%
Pepperstone
Advertisement
Registration Strip Icon for monitor Monitora più quotazioni in tempo reale dalle principali borse, come Borsa Italiana, NASDAQ, NYSE, AMEX, Bovespa e altro ancora.
Registrati

Quotazioni in diretta

Non abbiamo trovato risultati per:
Assicurati di aver scritto correttamente o prova ad allargare la ricerca.

Più Attivi

Toplist

Sembra che tu non sia connesso.
Clicca il pulsante qui sotto per accedere e visualizzare la tua cronologia recente.

Registrati

Sei già registrato? Accedi

Pepperstone

Inizia Ora

Pepperstone
Home Investire Azioni U.S.A. NASDAQ Fulgent Genetics Inc (FLGT) Fulgent Genetics Inc (FLGT) Notizie

Fulgent Genetics Inc

FLGT
18,51
-0,08 (-0,43%)
24 Dic 2024 - Chiuso
Dati in Delay di 15 minuti
Borsa: NASDAQ
Tipo: Azione
Valuta: USD

Ultime notizie

Data Ora Fonte Titolo
04/12/202422:41EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/12/202422:40EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/12/202401:10EDGAR2Form 144 - Report of proposed sale of securities
03/12/202401:10EDGAR2Form 144 - Report of proposed sale of securities
27/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
27/11/202423:00EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/11/202401:04EDGAR2Form 144 - Report of proposed sale of securities
26/11/202401:03EDGAR2Form 144 - Report of proposed sale of securities
08/11/202413:17EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
08/11/202413:10EDGAR2Form 8-K - Current report
08/11/202413:00BWFulgent Reports Third Quarter 2024 Financial Results
05/11/202414:00BWFulgent to Participate in Upcoming Conferences
01/11/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202413:00BWFulgent Genetics Awarded Contract by the U.S. Department of..
29/10/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/10/202421:30EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/10/202422:05BWFulgent to Announce Third Quarter 2024 Financial Results on..
05/9/202422:21EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/9/202422:20EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/9/202401:37EDGAR2Form 144 - Report of proposed sale of securities
30/8/202400:34EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/8/202400:33EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/8/202422:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
02/8/202413:38EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/8/202413:09EDGAR2Form 8-K - Current report
02/8/202413:00BWFulgent Reports Second Quarter 2024 Financial Results 
01/8/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/7/202422:27EDGAR2Form 4 - Statement of changes in beneficial ownership of..
11/7/202422:05BWFulgent to Announce Second Quarter 2024 Financial Results on..
04/6/202422:57EDGAR2Form 4 - Statement of changes in beneficial ownership of..
04/6/202422:56EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/6/202414:00BWFulgent Data at ASCO 2024 Highlights Antitumor Activity from..
28/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
24/5/202414:00BWFulgent Announces Upcoming Presentation of Clinical Data for..
21/5/202400:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
21/5/202400:04EDGAR2Form 4 - Statement of changes in beneficial ownership of..
16/5/202422:29EDGAR2Form 8-K - Current report
14/5/202422:05BWMoffitt Cancer Center and Fulgent Pharma Join Forces to..
07/5/202422:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
03/5/202413:00BWFulgent Reports First Quarter 2024 Financial Results
11/4/202422:05BWFulgent Genetics to Announce First Quarter 2024 Financial..
05/3/202422:28EDGAR2Form 4 - Statement of changes in beneficial ownership of..
05/3/202422:26EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
29/2/202401:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
28/2/202413:08EDGAR2Form 8-K - Current report
28/2/202413:00BWFulgent Reports Fourth Quarter and Full Year 2023 Financial..
28/2/202400:52EDGAR2Form 4 - Statement of changes in beneficial ownership of..
Apertura: 18,60 Min: 18,30 Max: 18,88
Chiusura: 18,59

La tua Cronologia

NASDAQ
FLGT
Fulgent Genetics
Delayed Upgrade Clock

Il sito ADVFN Italia è stato realizzato ed è gestito da PRODESFIN su licenza di ADVFN PLC.

PER CONTATTI E PUBBLICITA' SUL SITO CLICCARE QUI

Accedendo ai servizi offerti da ADVFN, ne si accettano le condizioni generali Termini & Condizioni

ADVFN Network